Radio and PodcastLive Radio & Podcasts

Search Radio and Podcast

Podcasts›Breast Cancer Update›HR-Positive Metastatic Breast Cancer — An Interview with Dr Seth Wander on Optimizing Biomarker Assessment and Related Treatment Decision-Making

Science & Medicine

HR-Positive Metastatic Breast Cancer — An Interview with Dr Seth Wander on Optimizing Biomarker Assessment and Related Treatment Decision-Making

Breast Cancer Update by Dr. Neil Love

Apr 16, 202601:00:13Science & Medicine

Dr Seth Wander from Massachusetts General Hospital in Boston discusses the role of biomarker assessment in the management of HR-positive metastatic breast cancer. CME information and select publications here .

Related Episodes

Continue listening to more episodes from Breast Cancer Update.

Oral SERDs for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

Apr 30, 2026 - 57:18

Dr Aditya Bardia from the University of California Los Angeles and Dr Erica Mayer from Dana-Farber Cancer...

ER-Positive, HER2-Positive Metastatic Breast Cancer — What Clinicians Want to Know About First-Line and Maintenance Therapy

Apr 14, 2026 - 57:59

Dr Virginia F Borges from the University of Colorado Anschutz Medical Campus in Aurora and Dr Ian E Krop...

Desmoid Tumors — Microlearning Activity 2 with Dr Ravin Ratan

Apr 7, 2026 - 28:14

Dr Ravin Ratan from The University of Texas MD Anderson Cancer Center in Houston discusses available clin...

Diabetology in Breast Cancer — Managing Hyperglycemia in Patients with Breast Cancer Receiving Agents Targeting the PI3K/AKT/PTEN Pathway

Mar 30, 2026 - 01:15:32

Ms Jaime Carroll from Mayo Clinic in Rochester, Minnesota, Professor Giuseppe Curigliano from the Europea...

Breast Cancer — 5-Minute Journal Club Issue 2 with Dr Lajos Pusztai: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays

Mar 18, 2026 - 30:21

Dr Lajos Pusztai from Yale Cancer Center in New Haven, Connecticut, discusses recent developments with ci...